Letermovir Prophylaxis in Solid Organ Transplant - CMV Breakthrough and Tacrolimus Drug Interaction

被引：0
|
作者：
Winstead, R. [1 ]
Kumar, D. [1 ]
Brown, A. [1 ]
Yakubu, I. [1 ]
Song, C. [1 ]
Thacker, L. [2 ]
Gupta, G. [1 ]
机构：
[1] Virginia Commonwealth Univ Hlth, Richmond, VA USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
821
引用
收藏
页码：844 / 844
页数：1
相关论文
共 50 条
  • [41] Polymyositis in solid organ transplant recipients receiving tacrolimus
    Vattemi, Gaetano
    Marini, Matteo
    Di Chio, Marzia
    Colpani, Maria
    Guglielmi, Valeria
    Tomelleri, Giuliano
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 345 (1-2) : 239 - 243
  • [42] Pharmacogenetics of Tacrolimus in Pediatric Solid Organ Transplant Recipients
    McLean, K.
    Gijsen, V.
    Fung, A.
    Daljevic, T.
    Nalli, N.
    Parekh, R.
    Kamath, B.
    Grasemann, H.
    Ito, S.
    Koren, G.
    Mital, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S138 - S138
  • [43] Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): Efficacy and drug interaction
    Shitrit, D
    Ollech, JE
    Ollech, A
    Bakal, I
    Saute, M
    Sahar, G
    Kramer, MR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12): : 2148 - 2152
  • [44] Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
    Jung, Susanne
    Michel, Manuela
    Stamminger, Thomas
    Michel, Detlef
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [45] Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
    Susanne Jung
    Manuela Michel
    Thomas Stamminger
    Detlef Michel
    BMC Infectious Diseases, 19
  • [46] Ways to boost cellular immunity in solid organ transplant recipients - The case of letermovir
    Abu-Omar, Amina
    Sester, Martina
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (01)
  • [47] Experience With Letermovir Use For The Management Of Cytomegalovirus In Solid Organ Transplant Recipients.
    Orejas, J. L.
    Marty, F. M.
    McDonnell, A. M.
    Cheng, M. P.
    Arbona-Haddad, E.
    Hammond, S. P.
    Koo, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 722 - 722
  • [48] Prolonged use of letermovir as CMV reactivation prophylaxis significantly reduces the risk of CMV reactivation in persistently immunocompromised stem cell transplant patients
    Koch, K.
    Osswald, L.
    Miller, I.
    Braitsch, K.
    Goetze, K.
    Bassermann, F.
    Herhaus, P.
    Verbeek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 242 - 242
  • [49] Breakthrough fungal infections in solid organ transplant (SOT) recipients receiving prophylaxis with isavuconazole and other antifungal agents
    Nguyen, M. H.
    Marini, R. M.
    Rivosecchi, R. M.
    Clarke, L.
    Shields, R. K.
    Clancy, C. J.
    MEDICAL MYCOLOGY, 2018, 56 : S29 - S29
  • [50] Cytomegalovirus (CMV) Prevention in Pediatric Solid Organ Transplant Recipients
    Suresh, S.
    Lee, B.
    Robinson, J.
    Akinwumi, M.
    Preiksaitis, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 236 - 237
12345